Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate
By M. Hall, James P. Unch, B. Binkowski, M. Valley, Braeden L. Butler, Monika G. Wood, Paul E. Otto, Kris Zimmerman, G. Vidugiris, T. Machleidt and 9 more. ACS Chemical Biology, 2012
1,420 citations recorded by the source corpus.
Bioluminescence methodologies have been extraordinarily useful due to their high sensitivity, broad dynamic range, and operational simplicity. These capabilities have been realized largely through incremental adaptations of native enzymes and substrates, originating from luminous organisms of diverse evolutionary lineages. We engineered both an enzyme and substrate in combination to create a novel bioluminescence system capable of more efficient light emission with superior biochemical and physical characteristics. Using a small luciferase subunit (19 kDa) from the deep sea shrimp Oplophorus gracilirostris, we have improved luminescence expression in mammalian cells ∼2.5 million-fold by merging optimization of protein structure with development of a novel imidazopyrazinone substrate (furimazine). The new luciferase, NanoLuc, produces glow-type luminescence (signal half-life >2 h) with a specific activity ∼150-fold greater than that of either firefly (Photinus pyralis) or Renilla luciferases similarly configured for glow-type assays. In mammalian cells, NanoLuc shows no evidence of post-translational modifications or subcellular partitioning. The enzyme exhibits high physical stability, retaining activity with incubation up to 55 °C or in culture medium for >15 h at 37 °C. As a genetic reporter, NanoLuc may be configured for high sensitivity or for response dynamics by appending a degradation sequence to reduce intracellular accumulation. Appending a signal sequence allows NanoLuc to be exported to the culture medium, where reporter expression can be measured without cell lysis. Fusion onto other proteins allows luminescent assays of their metabolism or localization within cells. Reporter quantitation is achievable even at very low expression levels to facilitate more reliable coupling with endogenous cellular processes.
Subfields: Cellular and Molecular Neuroscience, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/52dc4b8cd0ce3bc42838ecd65d5eb789237b2a66
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Molecular Biology
- J. Dauparas
- Samer F. Halabiya
- Ivan V. Anishchenko
- D. Tischer
- B. Coventry
- Lauren P. Carter
- Christoffer H Norn
Citations in the corpus
- De novo design of luciferases using deep learning (2023, background): “Overall, the specificity of our designed luciferases is much greater than that of native luciferases 35,36 or previously engineered luciferases 37 (Supplementary Table 5).”
- Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment (2018, positive): “For this purpose, we prepared a reporter construct by fusing nanoluc (nluc), a small and potent bioluminescence reporter 10 , to the C-terminus of CD63 which is one of the most widely used exosome markers 11 .”